Clinical Trial Update: Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating normoxemic versus hyperoxemic oxygenation in patients supported by veno-arterial ECMO for cardiogenic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Cardiogenic Shock, Extracorporeal Membrane Oxygenation | Phase 3 | Status: COMPLETED